Cochrane Systematic Review: Corticosteroids for Guillain-Barr syndrome
Hughes RA, van Doorn PA
Hughes RA, van Doorn PA
OBJECTIVES: To examine the ability of corticosteroids to hasten recovery and reduce the long-term morbidity from GBS.
OBJECTIVES: To examine the ability of corticosteroids to hasten recovery and reduce the long-term morbidity from GBS.
Cochrane Systematic Review: Plasma exchange for Guillain-Barr syndrome
Raphal JC, Chevret S, Hughes RA, Annane D
Raphal JC, Chevret S, Hughes RA, Annane D
OBJECTIVES: To assess the effects of plasma exchange for treating Guillain-Barre syndrome.
OBJECTIVES: To assess the effects of plasma exchange for treating Guillain-Barre syndrome.
Cochrane Systematic Review: Intravenous immunoglobulin for Guillain-Barr syndrome
Hughes RA, Swan AV, van Doorn PA
Hughes RA, Swan AV, van Doorn PA
OBJECTIVES: To determine the efficacy of IVIg for GBS.
OBJECTIVES: To determine the efficacy of IVIg for GBS.
Cochrane Systematic Review: Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barr syndrome
Hughes RA, Pritchard J, Hadden RD
Hughes RA, Pritchard J, Hadden RD
OBJECTIVES: To review systematically the evidence from randomised controlled trials (RCTs) for pharmacological agents other than plasma exchange, intravenous immunoglobulin and corticosteroids.
OBJECTIVES: To review systematically the evidence from randomised controlled trials (RCTs) for pharmacological agents other than plasma exchange, intravenous immunoglobulin and corticosteroids.
Cochrane Systematic Review: Corticosteroids for Guillain-Barr syndrome
Hughes RA, van Doorn PA
Hughes RA, van Doorn PA
OBJECTIVES: To examine the ability of corticosteroids to hasten recovery and reduce the long-term morbidity from GBS.
OBJECTIVES: To examine the ability of corticosteroids to hasten recovery and reduce the long-term morbidity from GBS.
Cochrane Systematic Review: Plasma exchange for Guillain-Barr syndrome
Raphal JC, Chevret S, Hughes RA, Annane D
Raphal JC, Chevret S, Hughes RA, Annane D
OBJECTIVES: To assess the effects of plasma exchange for treating Guillain-Barre syndrome.
OBJECTIVES: To assess the effects of plasma exchange for treating Guillain-Barre syndrome.
Cochrane Systematic Review: Intravenous immunoglobulin for Guillain-Barr syndrome
Hughes RA, Swan AV, van Doorn PA
Hughes RA, Swan AV, van Doorn PA
OBJECTIVES: To determine the efficacy of IVIg for GBS.
OBJECTIVES: To determine the efficacy of IVIg for GBS.
Cochrane Systematic Review: Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barr syndrome
Hughes RA, Pritchard J, Hadden RD
Hughes RA, Pritchard J, Hadden RD
OBJECTIVES: To review systematically the evidence from randomised controlled trials (RCTs) for pharmacological agents other than plasma exchange, intravenous immunoglobulin and corticosteroids.
OBJECTIVES: To review systematically the evidence from randomised controlled trials (RCTs) for pharmacological agents other than plasma exchange, intravenous immunoglobulin and corticosteroids.